Noteworthy Wednesday Option Activity: ROKU, OXY, DHR

Occidental Petroleum saw 50,014 options contracts trade today (≈5.0 million underlying shares), equal to about 43.4% of its one‑month average daily volume (11.5M shares), led by 18,996 contracts in the $50 call expiring March 20, 2026 (≈1.9M shares). Danaher recorded 13,224 option contracts (≈1.3M underlying shares), or roughly 42.5% of its one‑month average daily volume (3.1M shares), with 4,210 contracts in the $215 put expiring March 6, 2026 (≈421k shares). The large, concentrated option flows highlight significant positioning that could increase near‑term volatility and affect liquidity in the respective equity names.

Analysis

Market Structure: Large single-day call demand in OXY (18,996 contracts at $50 Mar 20 2026 ≈1.9M shares; ~43% of ADV) signals concentrated bullish positioning by a handful of players — direct winners: upstream energy equity holders (OXY, XOM, CVX) and options dealers receiving directional flow; losers: short-dated volatility sellers and low-beta utilities if oil shocks raise rates. For DHR, heavy March 6, 2026 $215 put flow (~421k shares; ~42% of ADV) reads as protective/put-buying or speculative downside, pressuring share price if dealers delta-hedge aggressively.

Risk Assessment: Tail risks include a >$15/bbl oil move (WTI) from geopolitical supply shocks that would re-rate OXY higher, or regulatory/antitrust/earnings surprises hurting DHR (product recalls, weaker organic growth). Immediate (days) risk: IV spikes and dealer gamma push; short-term (weeks–months): mean reversion of IV or catalytic earnings/FOMC moves; long-term (to Mar 2026): corporate actions (buybacks/dividends) or structural oil demand shifts. Hidden dependency: large option blocks may be hedges for convertible or structured products, not pure directional bets, muddying signal quality.

Trade Implications: Favor selective long-energy convexity vs idiosyncratic healthcare exposure. Volatility is elevated in both names — prefer defined-risk option structures (debit spreads for OXY, protective puts for DHR holders) and avoid naked short vol. Cross-asset: a meaningful OXY rally could widen credit spreads for non-energy corporates and lift inflation breakevens, pressuring long-duration bonds and strengthening commodity-linked FX (CAD, NOK).

Contrarian Angles: Consensus reads OXY flow as bullish and DHR as bearish, but flows may be corporate hedges or block trades; if so IV will mean-revert and create opportunities to sell premium. Historical parallel: concentrated option positioning has amplified moves (dealer gamma) then reversed when positions unwind — expect 10–25% intramonth seat-of-pants moves, not permanent direction without fundamental confirmation. Unintended consequence: aggressive dealer hedging may liquefy into momentum — trade size and timing matter.

Key Decisions for Investors

• Establish a capped 2% long-equity position in OXY by buying a directional, defined-risk call spread: buy OXY Mar 20 2026 $45/$55 call spread (1x notional) sized to equal ~2% portfolio exposure; target >2.5x P/L if OXY >$55 by expiry, stop-loss (roll/exit) if OXY < $40 within 6 months.
• If holding DHR or similar med-tech exposure, buy short-dated downside protection: purchase one Mar 06 2026 $200–$215 put (or equivalent put spread) sized to cover 50–100% of position for 0–3 month risk; consider trimming 1–2% outright equity exposure if cost of hedging >2% premium.
• Implement a pair trade for relative value: long XOM (1.5% portfolio) and short DHR (1.0% portfolio) to express commodity-driven cyclical tilt versus industrial/med-tech downside; reassess after 30–60 days or if oil moves >±10% from current levels.
• If opportunistic on volatility mean-reversion, sell OXY near-term calendar spreads: sell 30–60 day OXY straddle or call credit spreads only after IV spikes >30% above 90-day average; cap position gamma risk to <1.5% portfolio and close within 14 days or on 20% adverse move.